WallStreetZenWallStreetZen

NASDAQ: EFTR
Effector Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

EFTR past revenue growth

How has EFTR's revenue growth performed historically?
Company
148.46%
Industry
70.34%
Market
14.07%
EFTR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
EFTR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
EFTR's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

EFTR earnings and revenue history

Current Revenue
$3.6M
Current Earnings
-$35.7M
Current Profit Margin
-1,006.1%

EFTR Return on Equity

Current Company
-472.5%
Current Industry
-18%
Current Market
30.8%
EFTR's Return on Equity (-472.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when EFTR announces earnings.

EFTR Return on Assets

Current Company
-109%
Current Industry
0.9%
EFTR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

EFTR Return on Capital Employed

Current Company
704.64%
Current Industry
14.1%

EFTR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
EFTR$3.55M-$33.21M-$35.75M-52.38%N/A
LTRN$0.00-$13.85M-$14.01MN/AN/A
VIRX$0.00-$49.25M-$50.86M-100.00%N/A
IMNM$2.36M-$28.87M-$30.14MN/AN/A
IOBT$0.00-$69.02M-$71.30MN/AN/A
View Top Biotech Stocks

EFTR earnings dates

Next earnings date
Aug 7, 2023

Effector Therapeutics Earnings & Revenue FAQ

What were EFTR's earnings last quarter?

On Invalid Date, Effector Therapeutics (NASDAQ: EFTR) reported Q1 2023 earnings per share (EPS) of -$0.24, up 400% year over year. Total Effector Therapeutics earnings for the quarter were -$10.01 million. In the same quarter last year, Effector Therapeutics's earnings per share (EPS) was $0.08.

If you're new to stock investing, here's how to buy Effector Therapeutics stock.

What was EFTR's earnings growth in the past year?

As of Q2 2023, Effector Therapeutics's earnings has grown year over year. Effector Therapeutics's earnings in the past year totalled -$35.75 million.

What is EFTR's earnings date?

Effector Therapeutics's earnings date is Invalid Date. Add EFTR to your watchlist to be reminded of EFTR's next earnings announcement.

What was EFTR's revenue last quarter?

On Invalid Date, Effector Therapeutics (NASDAQ: EFTR) reported Q1 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Effector Therapeutics's revenue was $0.00.

What was EFTR's revenue growth in the past year?

As of Q2 2023, Effector Therapeutics's revenue has grown 148.46% year over year. This is 78.12 percentage points higher than the US Biotechnology industry revenue growth rate of 70.34%. Effector Therapeutics's revenue in the past year totalled $3.55 million.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.